Growth suppression by ursodeoxycholic acid involves caveolin-1 enhanced degradation of EGFR
- 31 August 2009
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1793 (8) , 1387-1394
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- The Inhibitory Effect of (−)-Epigallocatechin Gallate on Activation of the Epidermal Growth Factor Receptor Is Associated with Altered Lipid Order in HT29 Colon Cancer CellsCancer Research, 2007
- Bile acid induces hydrophobicity-dependent membrane alterationsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2005
- c-Cbl-mediated Ubiquitinylation Is Required for Epidermal Growth Factor Receptor Exit from the Early EndosomesJournal of Biological Chemistry, 2004
- Loss of Caveolin-1 Gene Expression Accelerates the Development of Dysplastic Mammary Lesions in Tumor-Prone Transgenic MiceMolecular Biology of the Cell, 2003
- Caveolin‐mediated regulation of signaling along the p42/44 MAP kinase cascade in vivoFEBS Letters, 1998
- Different bile acids exhibit distinct biological effects: The tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferationNutrition and Cancer, 1998
- Interaction of a Receptor Tyrosine Kinase, EGF-R, with CaveolinsJournal of Biological Chemistry, 1997
- Control of EGF Receptor Signaling by Clathrin-Mediated EndocytosisScience, 1996
- GROWTH FACTOR RECEPTOR TYROSINE KINASESAnnual Review of Biochemistry, 1988
- Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practicesInternational Journal of Cancer, 1975